Closing the Historic Routine-Vaccination Gap
Drug Topics
OCTOBER 11, 2022
Pharmacists can play a key role in helping to improve backsliding vaccination rates.
Tue.Oct 11, 2022
591 
Citius Pharmaceuticals sees golden opportunities in late-stage specialty assets
PharmaVoice
OCTOBER 11, 2022
CEO Leonard Mazur explains how the company’s hoping to unlock the potential of its varied pipeline.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
What CBD Brings to the Table for Dermatologic Concerns
Drug Topics
OCTOBER 11, 2022
Drug Topics® is joined by Dr. Alex Capano, Chief Science Officer at Ananda professional to discuss what CBD is used for in dermatology.
Harnessing the creative energy of California, Alto is advancing a novel approach to psychiatric meds
PharmaVoice
OCTOBER 11, 2022
After making the leap from academia to the world of biotech, CEO Dr. Amit Etkin is hoping to shift the treatment paradigm for neurological conditions.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
The Power of Community: Pharmacists Share Their Experiences With Service Expansion
Drug Topics
OCTOBER 11, 2022
When looking to expand pharmacy services, buying groups can be an invaluable resource.
Women Pharmacist Day Celebrates Trailblazers in the Field
Pharmacy Times
OCTOBER 11, 2022
Suzanne Soliman, PharmD, BCMAS, discusses how she will be celebrating the important contributions of women pharmacists.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Study: High Doses of Vitamin D Do Not Improve Heart, Circulatory Health
Pharmacy Times
OCTOBER 11, 2022
Additionally, the new data found that vitamin D supplements do not offer support prevention of a number of health issues as is commonly believed.
First-in-Class Treatment for Obstructive Hypertrophic Cardiomyopathy Is Approved by FDA
Drug Topics
OCTOBER 11, 2022
Mavacamten improves functional capacity and symptoms in adults with New York Heart Association class II-III obstructive HCM.
Intravenous Immune Globulin May Improve Dermatomyositis Symptoms in Adults
Pharmacy Times
OCTOBER 11, 2022
Study data showed that more than three-quarters of patients with dermatomyositis who received intravenous immune globulin therapy experienced improved symptoms.
Seqirus Receives Government Contract to Develop 2 Flu Vaccines
Drug Topics
OCTOBER 11, 2022
The vaccines will utilize the company’s technology in a bid to protect against pandemic influenza.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
2022 CVS Health Minority Scholarship For Pharmacy Students Winners Announced
Pharmacy Is Right For Me
OCTOBER 11, 2022
We’re thrilled to announce the winners of the 2022 CVS Health Minority Scholarship for Pharmacy Students! The CVS Health Minority Scholarship for Pharmacy Students is a scholarship program launched in 2019 thanks to the generosity of CVS Health in partnership with the American Association of Colleges of Pharmacy (AACP). About this scholarship program The scholarship program is designed to support and promote a diverse population of student pharmacists by reducing financial barriers for underrepr
Stelara Study Shows Efficacy for Ulcerative Colitis
Drug Topics
OCTOBER 11, 2022
Clinical trial results reported at United European Gastroenterology Week 2022 highlight Stelara's effectiveness.
Maternity care ‘deserts’ on the rise across the U.S., report finds
STAT
OCTOBER 11, 2022
The home birth had been going well, with the baby having been delivered safely, when midwife Lauren Genter noticed that the mother was losing more blood than normal. The family was Amish and didn’t have a phone in the house, so Genter took her cellphone to the one window where she had spotty service to call for an ambulance. She was able to keep the mother stable while they waited.
Wellcome funds work on regulating digital mental health tools
pharmaphorum
OCTOBER 11, 2022
An explosion of digital mental health tools being offered for sale has presented regulators with a problem – how should they be classified and assessed for safety or efficacy? Wellcome has provided funding in the UK to help answer that question. The healthcare charity is providing £1.8 million (around $2 million) in financial support for UK health technology assessment (HTA) agency NICE and medicines regulator MHRA to develop guidance on “appropriate, risk-proportionate regulation of digit
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
U.S. preventive health group recommends anxiety screening for kids 8 to 18
STAT
OCTOBER 11, 2022
An influential national panel of preventive health experts on Tuesday recommended for the first time that children and adolescents between 8 and 18 should be screened for anxiety, but said there was insufficient evidence to say that children 7 and under should be screened. The new recommendations, issued by the U.S. Preventive Services Task Force and published in JAMA, are for the screening of children and teens who are seen in primary care settings and have no symptoms.
AstraZeneca’s intranasal COVID vaccine fails first clinical test
pharmaphorum
OCTOBER 11, 2022
An intranasal formulation of AstraZeneca’s widely-used COVID-19 vaccine Vaxzevria has failed at the first hurdle, after results from a phase 1 trial found it was unable to stimulate a strong immune response to the virus. The 30-subject study – funded by AZ and published in the Lancet journal eBioMedicine – tested two strengths of the current formulation of the vaccine administered as a nasal spray, with half the group receiving a second intranasal dose 28 days later, and half getting a reg
Kidney Transplant Provides Greater Benefit Than Long-Term Dialysis for Patients With Kidney Failure
Pharmacy Times
OCTOBER 11, 2022
Although survival benefits for patients who received a kidney transplant varied, the benefits of kidney transplants were greater for all patients when compared with long-term dialysis.
Outshine’s Smoothie Cubes feature Vital Proteins Collagen Peptides
Drug Store News
OCTOBER 11, 2022
Outshine Smoothie Cubes are available in Go-Getter, Glow To and Gut Supporter vairties.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT+: For Swedish professor and his tiny biotech, Alzheimer’s drug means vindication and a fortune
STAT
OCTOBER 11, 2022
Last month, word spread that a drug was finally shown to slow Alzheimer’s disease, and overnight a 73-year-old Swedish professor made $350 million. The lucky man, Lars Lannfelt, was not particularly famous. He had done pioneering work on the disease, but it was in the 90s and belonged to a sub-field that, after a litany of failures and one disastrous approval, had fallen from grace.
UK economy shrinks by 0.3% on back of manufacturing slump
The Guardian - Pharmaceutical Industry
OCTOBER 11, 2022
August GDP data from ONS gives strong signal that UK is entering recession Business live updates: UK economy shrinks in August Britain’s economy shrank by 0.3% in August from July, hit by a slump in manufacturing and by maintenance work that slowed the oil and gas sector, official data showed. Giving a strong signal that the UK is entering a recession , the Office for National Statistics said manufacturing declined by 1.6% while the cost of living crisis appeared to hit hotels, restaurants and t
Opinion: CBO’s dismissal of health care price transparency is based on faulty premises
STAT
OCTOBER 11, 2022
Can price transparency meaningfully reduce the outrageous cost of health care and coverage? I believe it can. So do the last several presidential administrations, led by Democrats and Republicans, and nearly 90% of Americans, according to numerous recent polls. The Congressional Budget Office (CBO), however, doesn’t seem to think highly of transparency.
Francisco Partners to acquire bswift from CVS Health
Drug Store News
OCTOBER 11, 2022
Bswift will continue to partner with CVS Health and Aetna, a CVS Health company, to provide benefits technology to its employees and client base.
STAT+: As small-town telepharmacies struggle to stay open, national chains eye an opportunity
STAT
OCTOBER 11, 2022
In February 2019, the town of Albion, Ind. — population 2,500 — welcomed its first pharmacy in more than a decade. The Pill Box Pharmacy opened with a ribbon-cutting ceremony and a plaque to commemorate a special milestone: It would be the state’s first telepharmacy. Behind the counter, a pharmacy technician would beam orders and snapshots of pills to a licensed pharmacist somewhere offsite for review before doling out medications to Albion residents.
Keeping it Simple
PharmExec
OCTOBER 11, 2022
Bristol Myers Squibb commercial head Chris Boerner believes a straightforward formula is the best formula in advancing innovation and developing talent in today’s complex healthcare climate—an approach he roots in authenticity and “not over engineering,” whether tackling business or culture.
Hurricane Ian: What You Need to Know and How You Can Help
PioneerRx
OCTOBER 11, 2022
The impact and devastation brought about by Hurricane Ian are well documented. At the time of writing, Hurricane Ian has caused at least 130 fatalities and.
Retailers ramp up initiatives to drive equity, diversity and sustainability
Drug Store News
OCTOBER 11, 2022
Drug store chains strengthen their program efforts and service activities to maximize community impact.
At the Heart of Pharma: ESG has Arrived as a Central Strategy
PharmExec
OCTOBER 11, 2022
Pharma supply chains are no longer hidden beyond the reach of ESG agendas, making it important for companies to accelerate adoption of new manufacturing processes and environmental technology.
How to Successfully Employ External Comparator Arm Studies Using Real World Data
pharmaphorum
OCTOBER 11, 2022
Despite randomised clinical trials (RCTs) being the gold standard for drug approval studies, the shift towards precision medicine has increased the use of single-arm trials (SATs). SATs lack results from control patients. Therefore, to help contextualise study findings, external comparator arms (ECAs) can be employed, which compile data from external sources, such as patient registries and other medical records.
Beauty consumers on the demand for transparency
Drug Store News
OCTOBER 11, 2022
A new report by Beauty Pie, released in partnership with The Future Laboratory, examines how consumers are now armed with greater access to product efficacy and supply chain efforts.
Frontiers Health Steering Committee spotlight – Paul Tunnah
pharmaphorum
OCTOBER 11, 2022
As the Frontiers Health 2022 conference in Milan on 20th to 21st October draws ever nearer, pharmaphorum has been catching up with members of the event’s Steering Committee to find out more about what drives both them and the event itself. This time, Paul Tunnah – pharmaphorum’s very own founder and chief content officer and managing director UK at Healthware Group – discussed healthcare’s digital transformation (this year’s guiding theme) and his own journey into the digital space.
EnsembleIQ honors women leaders with awards
Drug Store News
OCTOBER 11, 2022
The company created 9 awards programs designed to recognize women leaders across the retail, technology, consumer goods, health care and hospitality industries.
New initiative will calculate carbon footprint of clinical trials
European Pharmaceutical Review
OCTOBER 11, 2022
The Pistoia Alliance, a non-profit advocating R&D collaboration in life sciences, has launched the Clinical Trials Environmental Impact Community of Interest (CoI) , a collaborative initiative that aims to calculate the carbon footprint of centralised and decentralised clinical trials, enabling a standard that companies can use to calculate a clinical trial’s carbon impact.
STAT+: Bright exits ACA health insurance marketplaces to stay afloat
STAT
OCTOBER 11, 2022
Bright Health Group is drastically cutting back its health insurance offerings for next year, including a full exit of the individual Affordable Care Act marketplaces, and is attempting to raise $175 million to keep the company afloat. The financially troubled company’s new strategy is an abrupt turn from its recent public intentions. Over the summer, Bright filed documents with states like Alabama , Florida , and Georgia , anticipating it would continue to sell ACA plans next year even a
Let's personalize your content